400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2000033012
尚未开始
/
/
/
2020-05-18
/
/
Mayer-Rokitansky-Küster-Hauser (MRKH)
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome
In this study, we aim to evaluate the management of women who suffered from MRKH syndrome and evaluate the outcomes of vaginal dilation therapy or surgical therapy and the associated complications. Besides, it is also valuable to study the sexual function of women to guide the future treatment plan for other MRKH women.
单臂
其它
N/A
/
Departmental funding
/
300
/
2020-05-20
2030-04-30
/
1) All women who suffered from MRKH and requested for vaginoplasty; 2) Age >=18 years old.；
请登录查看Women who refuse to join the study.；
请登录查看Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong
/
求实药社2026-07-16
医药观澜2026-07-16
BioArt2026-07-16
一度医药2026-07-16
医药笔记2026-07-16
医药笔记2026-07-16
杏泽资本2026-07-16
药明康德2026-07-16
中国北京同仁堂官微2026-07-15
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
